Weber Alan W bought a new stake in shares of Digirad Co. (NASDAQ:DRAD) during the first quarter, HoldingsChannel reports. The fund bought 100,000 shares of the medical equipment provider’s stock, valued at approximately $91,000.
Separately, ValuEngine upgraded Digirad from a “hold” rating to a “buy” rating in a research note on Thursday, June 6th.
In other news, Director Jeffrey E. Eberwein bought 85,000 shares of the stock in a transaction dated Wednesday, May 8th. The stock was bought at an average price of $0.66 per share, for a total transaction of $56,100.00. Following the purchase, the director now directly owns 644,152 shares in the company, valued at approximately $425,140.32. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last 90 days, insiders bought 158,538 shares of company stock valued at $103,800. 7.30% of the stock is currently owned by company insiders.
Digirad (NASDAQ:DRAD) last released its earnings results on Friday, May 3rd. The medical equipment provider reported ($0.50) EPS for the quarter. The firm had revenue of $23.91 million during the quarter. Digirad had a negative net margin of 4.90% and a negative return on equity of 9.16%.
COPYRIGHT VIOLATION WARNING: This piece was published by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.baseballdailydigest.com/news/2019/06/16/weber-alan-w-invests-91000-in-digirad-co-nasdaqdrad.html.
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.
Read More: What defines an oversold asset?
Want to see what other hedge funds are holding DRAD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Digirad Co. (NASDAQ:DRAD).
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.